Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.

NCT: NCT03423485 · COMPLETED

NCT IDNCT03423485
StatusCOMPLETED
Start Date2018-01-01
Completion2018-12-15
SponsorColospan Ltd. (INDUSTRY)
First posted
Last updated

Brief Summary

The purpose of this study is to evaluate the CG-100 device, a single use, temporary intraluminal bypass device,intended to reduce contact of fecal content with an anastomotic site, following colorectal surgery (open or laparoscopic)

Frequently Asked Questions

What is Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.?

Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery. is a clinical trial registered under NCT03423485. Current status: COMPLETED.

What is the status of NCT03423485?

The current status of NCT03423485 (Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery.) is: COMPLETED.

When did Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery. start?

Safety and Performance of the CG-100 in Patients Undergoing Colorectal Surgery. started on 2018-01-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.